(E)-3-(3-Bromophenyl)-1-(4-methylphenyl)prop-2-en-1-one

The title compound, C16H13BrO, was synthesized from the reaction of 3-bromobenzaldehyde and 4-methylacetophenone in the presence of KOH. The molecule adopts an E configuration with respect to the C=C double bond of the propenone unit. The dihedral angle formed by the aromatic rings is 46.91 (14)°. The crystal structure is stabilized by Br⋯Br interactions [3.4549 (11) Å].

[1]  Suman Gupta,et al.  Chemotherapy of leishmaniasis part II: synthesis and bioevaluation of substituted arylketene dithioacetals as antileishmanial agents. , 2005, European journal of medicinal chemistry.

[2]  H. S. Yathirajan,et al.  (2E)-1-(2-hydroxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one , 2007 .

[3]  K. Schønning,et al.  Cationic chalcone antibiotics. Design, synthesis, and mechanism of action. , 2005, Journal of medicinal chemistry.

[4]  N. Lawrence,et al.  Linked parallel synthesis and MTT bioassay screening of substituted chalcones. , 2001, Journal of combinatorial chemistry.

[5]  H. Fujita.  [Anticancer drugs]. , 1995, Nihon rinsho. Japanese journal of clinical medicine.

[6]  G. Sheldrick.  A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.

[7]  J. Gut,et al.  Synthesis and antimalarial activity of sulfonamide chalcone derivatives. , 2005, Farmaco.

[8]  M. Conti.  Cyclopentenone: a special moiety for anticancer drug design , 2006, Anti-cancer drugs.